- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Influenza A rapid test kit |
| Catalog No. | IP-00188 |
| Description | The influenza A rapid test kit is a diagnostic tool used to quickly detect the presence of influenza A in humans. |
| Sample Type | Swab/nasal aspirate |
| Application | This product can be used for rapid in vitro screening of influenza A. |
| Operating Temperature | Store at 4-30°C. |
| Transportation Condition | Transportation at room temperature. |
Influenza A virus, a member of the Orthomyxoviridae family, is a highly contagious respiratory pathogen that poses a significant threat to global public health. Each year, seasonal influenza A outbreaks cause millions of cases of mild to severe illness, leading to hospitalizations and even deaths—especially among vulnerable groups such as the elderly, young children, pregnant women, and individuals with chronic underlying conditions. Beyond seasonal outbreaks, influenza A viruses (e.g., H1N1, H3N2 subtypes) have also been responsible for historic pandemics, highlighting the critical need for rapid and accurate detection to control spread.
The Influenza A Rapid Test Kit (also known as Influenza A Antigen Rapid Detection Kit, Influenza A Quick Test Kit, or Flu A Rapid Diagnostic Test Kit) is a vital tool in the fight against influenza A. Unlike traditional laboratory methods (such as reverse transcription-polymerase chain reaction, RT-PCR) that require specialized equipment and 24-48 hours for results, this rapid test kit leverages immunochromatographic technology to detect influenza A viral antigens directly from respiratory specimens (e.g., nasal swabs, throat swabs) in a short time.
Key reasons for the importance of this product:
Early Intervention: Rapid detection (within 10-15 minutes) allows clinicians to initiate antiviral treatment promptly—most effective when started within 48 hours of symptom onset—reducing the severity and duration of illness.
Containment of Spread: Identifying influenza A cases quickly helps implement isolation measures (e.g., in schools, workplaces, or hospitals), preventing further transmission within communities.
Reduction of Misdiagnosis: Influenza A symptoms (fever, cough, sore throat, fatigue) overlap with other respiratory illnesses like COVID-19, RSV, or the common cold. This kit helps differentiate influenza A from these conditions, avoiding unnecessary use of antibiotics or incorrect treatment protocols.
Public Health Surveillance: Aggregated data from rapid test results aids public health agencies in tracking influenza A outbreaks, monitoring subtype prevalence, and adjusting prevention strategies (e.g., vaccine distribution) in real time.
Rapid Result Turnaround: Delivers accurate test results in just 10-15 minutes, a fraction of the time required for lab-based RT-PCR tests. This speed is critical for urgent clinical settings (e.g., emergency rooms, urgent care centers) where timely decisions are essential.
Minimal Specimen Requirement: Requires only a small volume of respiratory specimen (e.g., 50-100 μL of swab eluate), making sample collection non-invasive and comfortable for patients—especially children and elderly individuals who may struggle with more complex sampling methods.
No Specialized Equipment Needed: Operates without the need for centrifuges, thermal cyclers, or other expensive lab equipment. The kit includes all necessary components (test strips, sample buffer, swabs), enabling on-site testing in primary care clinics, schools, or remote areas.
Broad Subtype Detection: Effectively detects major circulating influenza A subtypes, including H1N1 (pandemic and seasonal strains) and H3N2. This versatility ensures the kit remains useful even as viral strains evolve seasonally.
Stable Storage and Transportation: Maintains optimal performance when stored at 2-30°C (no refrigeration required for short-term storage) and can be transported at room temperature. This eliminates cold chain logistics costs and reduces the risk of product degradation during shipping.
Time-Efficient: Quick results enable prompt diagnosis and treatment, which is crucial during peak flu seasons.
Cost-Effective: Simple and rapid testing procedure reduces overall costs compared to more complex laboratory methods.
User-Friendly: Designed for ease of use, allowing healthcare professionals with minimal training to perform the test.
Supports Public Health Initiatives: Enables large-scale screening and early detection, which are essential for controlling outbreaks and reducing the spread of influenza.
Accurate and Reliable: High sensitivity and specificity ensure accurate results, aiding in the effective management of influenza cases.
For in vitro diagnostic use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
